A phase 1/2a dose-finding study and biomarker assessment of oral lisavanbulin in patients with high-grade glioma or glioblastoma. - Lopez JS; Haefliger S; Plummer R; Clement PM; Jeffry Evans TR; Läubli H; Roth P; Kristeleit R; Brazil L; Tabatabai G; Wick A; Wunderlich B; et al. (Cell reports. Medicine, 2025)